To The Main Page
About RTC Our Projects Stem Cell Therapy Research Translation Service/Technology Transfer Contact
Good Laboratory Practise
Good Clinical Practise
Good Vigilance Practise
Good Manufacturing Practise
Network and Publications

Important regulatory institutions:

 European Agency for the Evaluation of Medicinal Products (EMEA)
European Commission, Enterprise & Industry, Pharmaceuticals
European Heads of Medicines Regulatory Agencies
Federal Institute for Drugs and Medical Devices
Institute for Quality and Efficiency in Health Care
Federal Joint Committee
Medical Service of the Healthy Insurance
Institute for the Hospital Remuneration System
The Patent & Valorisation Agency – Mecklenburg-Vorpommern AG


Our partners

Competence-liasion cardiac stem cell therapy

German Heart Institute Berlin
Hannover Medical School

University Heart Center Hamburg
University Heart Center Leipzig
Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen

Industry partners

Miltenyi Biotec GmbH
Advanced Therapies Partners GmbH (ATP)
Seracell Stammzelltechnologie GmbH
Biotronik GmbH
Pall Corporation

General partners

Institut für Regenerative Medizin und Stammzelltherapie e.V. (IRMED)
Berlin-Brandenburger Centrum für Regenerative Therapien, BCRT, Berlin
DFG-Forschungszentrum für Regenerative Therapien, Dresden
Zentrum für Regenerative Medizin, REBIRTH, Hannover 
Translationszentrum Regenerative Medizin, TRM, Leipzig
Regenerative Medicine Initiative Germany (RMIG)
RIKEN Zentrum für Entwicklungsbiologie, Kobe, Japan




Erben RG, Silva-Lima B, Reischl I, Steinhoff G, Tiedemann G, Dalemans W, Vos A, Janssen RT, Le Blanc K, van Osch G Phd, Luyten FP. White paper on how to go forward with cell-based Advanced Therapies in Europe. Tissue Eng Part A. 2014 Apr 22. [Epub ahead of print]
Tiedemann G, Sethe S. (2011). Regulatory Frameworks for Cell and Tissue Based Therapies in Europe and the USA, in: „Regenerative Medicine – from protocol to patient“, Ed: Gustav Steinhoff, Springer Netherlands.  
Tiedemann G, Wagner A.
RegMed-Regularien im Praxistest: Herausforderungen und Hemmnisse der Translation
Regenerative Medizin, Heft 1/2011: 21-25
Tiedemann G, Wagner A.
Regenerative Medizin: Potenziale eines ressourcenorientierten Behandlungsprinzips für (Verschleiß-)Krankheiten im Alter
B&G Bewegungstherapie und Gesundheitssport, 2.2011: 70-73
Steinhoff, G; Tiedemann, G; Thalheimer, M; Ho, AD
From basic research to the clinic. Regulations for preclinical and clinical studies with stem cells
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):973-9. German.


Legal The RTC is supported by the BMBF and the State Mecklenburg-Western Pomerania using EU Structural Funds.